GSA Capital Partners’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.18M | Buy |
|
|||||
|
2025
Q2 | $766K | Sell |
|
|||||
|
2025
Q1 | $804K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $742K | Sell |
|
|||||
|
2024
Q1 | $2.04M | Sell |
|
|||||
|
2023
Q4 | $2.07M | Buy |
|
|||||
|
2023
Q3 | $1.05M | Buy |
|
|||||
|
2023
Q2 | $463K | Buy |
|
|||||
|
2023
Q1 | $428K | Buy |
|
|||||
|
2022
Q4 | $143K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $418K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $55K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $155K | Sell |
|
|||||
|
2020
Q1 | $352K | Sell |
|
|||||
|
2019
Q4 | $525K | Buy |
|
|||||
|
2019
Q3 | $376K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $90K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $52K | Buy |
|